| 英文别名 |
(S)-5-Chloro Naproxen;(2S)-2-(5-chloro-6-methoxynaphthalen-2-yl)propanoic acid;(S)-5-Chloro-6-Methoxy-α-Methyl-2-naphthaleneacetic Acid;UNII-R60QH2454J;(αS)-5-Chloro-6-methoxy-α-methyl-2-naphthaleneacetic acid;(2S)-2-(5-Chloro-6-methoxy-2-naphthyl)propionic acid;Naproxen Impurity B;(S)-5-Chloronaproxen;(αS)-5-Chloro-6-methoxy-α-methyl-2-naphthaleneacetic acid (ACI);2-Naphthaleneacetic acid, 5-chloro-6-methoxy-α-methyl-, (S)- (ZCI);(2S)-2-(5-Chloro-6-methoxynaphthalen-2-yl)propanoic Acid (5-Chloronaproxen);NAPROXEN IMPURITY B [EP IMPURITY];RVVAYDHIVLCPBC-QMMMGPOBSA-N;NAPROXEN SODIUM IMPURITY B [EP IMPURITY];CS-0377788;Naproxen impurity B [EP];2-NAPHTHALENEACETIC ACID, 5-CHLORO-6-METHOXY-.ALPHA.-METHYL-, (.ALPHA.S)-;89617-86-7;F74802;(S)-5-Chloro-6-Methoxy-;NS00133301;(2S)-2-(5-Chloro-6-methoxynaphthalen-2-yl)propanoic Acid; Naproxen Imp. B (EP); 5-Chloronaproxen; Naproxen Impurity B;SCHEMBL9486872;Q27287842;A-Methyl-2-naphthaleneacetic Acid;5-Chloronaproxen, (S)-;(2S)-2-(5-Chloro-6-methoxynaphthalen-2-yl)propanoic acid, pharmaceutical impurity standard;R60QH2454J;(S)-2-(5-Chloro-6-methoxynaphthalen-2-yl)propanoic acid;5-Chloro naproxen, (+)-;5-Chloro naproxen, (S)-;2-Naphthaleneacetic acid, 5-chloro-6-methoxy-alpha-methyl-, (alphaS)-;MFCD27967013;Naproxen sodium impurity B [EP];(S)-2-(5-chloro-6-methoxy-2-naphthyl)-propionic acid;(S)-5-Chloro-6-Methoxy-alpha-Methyl-2-naphthaleneacetic Acid |